Latigo Biotherapeutics Inc. (LTGO) Stock Ticker
LTGO right now
Market factors today
Unlock the full LTGO picture
About Latigo Biotherapeutics Inc.
Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.
LTGO stock facts
| Ticker symbol | LTGO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| Market cap | $1.0B |
| CEO | Nima Farzan |
| Employees | 66 |
| Headquarters | Thousand Oak, CA, US |
| IPO date | 2026-08-07 |
| Website | www.latigobio.com |
What you can see for LTGO on Tickr
Live LTGO price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the LTGO report.
Rankings
FAQ
What is the ticker symbol for Latigo Biotherapeutics Inc.?
The ticker symbol for Latigo Biotherapeutics Inc. is LTGO, listed on the NASDAQ.
What is LTGO?
Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is…